ÀÌ´ëºñ´¢ÀÇÇаú Ãß°èÇмú´ëȸ : 2023-10-14
±³À°ÀÏÀÚ : 2023-10-14
±³À°Àå¼Ò : À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ 2Ãþ)
±³À°ÁÖÁ¦ : ÀÌ´ëºñ´¢ÀÇÇаú Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : À̴뼿ﺴ¿ø
´ã´çÀÚ : ±è°æ¹Î
¿¬¶ôó : 02-2650-5801
À̸ÞÀÏ : 9a277@eumc.ac.kr
±³À°Á¾·ù : ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, º´¸®°ú, ÀÇ·á»çȸÇÐ
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 14ÀÏ À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ 2Ãþ) 10:30~10:50 Fusion biopsy in EUMC ÀÌÈ¿Á¤(ÀÌÈ¿©´ë)
±³À°½Ã°£ 10¿ù 14ÀÏ À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ 2Ãþ) 10:50~11:10 Diagnosis of prostate cancer using urine biomarkers ±èû¼ö(ÀÌÈ¿©´ë)
±³À°½Ã°£ 10¿ù 14ÀÏ À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ 2Ãþ) 11:10~11:30 F18 Florastamin(PSMA) PET ÀÌÁö¿(°¡Å縯´ë)
±³À°½Ã°£ 10¿ù 14ÀÏ À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ 2Ãþ) 11:30~11:50 Use of Big Data and Artificial Intelligence in Healthcare ¿ìÁ¾ÇÊ(¼¼Á¾´ë)
±³À°½Ã°£ 10¿ù 14ÀÏ À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ 2Ãþ) 11:50~12:10 Artificial Intelligence in medicine ±èÈÖ¿µ(¿¬¼¼´ë)
±³À°½Ã°£ 10¿ù 14ÀÏ À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ 2Ãþ) 12:10~12:30 Artificial Intelligence in Urology ½ÅÅ¿µ(ÀÌÈ¿©´ë)
½Ä»ç 10¿ù 14ÀÏ À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ 2Ãþ) 12:30~13:30 Lunch ()
±³À°½Ã°£ 10¿ù 14ÀÏ À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ 2Ãþ) 13:30~13:50 Radical cystectomy with orthotopic neobladder in EUMC ±è¸í¼ö(ÀÌÈ¿©´ë)
±³À°½Ã°£ 10¿ù 14ÀÏ À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ 2Ãþ) 13:50~14:10 Perioperative chemotherapy in Muscle Invasive Bladder Cancer Á¶Á¤¹Î(ÀÌÈ¿©´ë)
±³À°½Ã°£ 10¿ù 14ÀÏ À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ 2Ãþ) 14:10~14:30 Micropapillary and plasmacytoid subtypes of urothelial carcinoma; focused on histology, molecular alteration and chemotherapy effect Á¤¼¼¿î(ÀÌÈ¿©´ë)
ÈÞ½Ä 10¿ù 14ÀÏ À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ 2Ãþ) 14:30~15:00 Coffee Break ()
±³À°½Ã°£ 10¿ù 14ÀÏ À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ 2Ãþ) 15:00~15:20 Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1 Application of RNA trans-splicing ribozyme in urologic cancer. Takashi Kobayashi(Kyoto University, Japan)
±³À°½Ã°£ 10¿ù 14ÀÏ À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ 2Ãþ) 15:20~15:40 Is molecular subtyping of bladder cancer applicable in our clinical settings? Ryoichi Saito(Kyoto University, Japan)
±³À°½Ã°£ 10¿ù 14ÀÏ À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ 2Ãþ) 15:40~16:00 Application of RNA trans-splicing ribozyme in urologic cancer À̼º¿í(´Ü±¹´ë)
±³À°½Ã°£ 10¿ù 14ÀÏ À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ 2Ãþ) 16:00~16:20 Investigational research of lipid biomarkers in prostate cancer using tissue and urine samples Takayuki Goto(Kyoto University, Japan)